TipRanks
Go Ultimate55% OFF

Compare Shanghai Junshi Biosciences Co., Ltd. Class H (SHJBF) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
SHJBFShanghai Junshi Biosciences Co., Ltd. Class H$3.35$3.83B-69.155.02%Moderate BuyUnlock the SHJBF analyst price target with TipRanks PremiumSHJBFUnlock the SHJBF top-analyst price target with TipRanks Premium
HK:1801Innovent BiologicsHKD 80.65HKD 139.32B95.40-7.30%Strong BuyUnlock the HK:1801 analyst price target with TipRanks PremiumSHJBF vs HK:1801Unlock the HK:1801 top-analyst price target with TipRanks Premium
HK:9688Zai Lab LtdHKD 17.28HKD 21.69B-12.70-14.03%Strong BuyUnlock the HK:9688 analyst price target with TipRanks PremiumSHJBF vs HK:9688Unlock the HK:9688 top-analyst price target with TipRanks Premium
HK:9926Akeso, Inc.HKD 78.90HKD 76.70B-66.36-30.42%Strong BuyUnlock the HK:9926 analyst price target with TipRanks PremiumSHJBF vs HK:9926Unlock the HK:9926 top-analyst price target with TipRanks Premium
HK:9995RemeGen Co. Ltd. Class HHKD 65.90HKD 51.82B7.89-26.78%Strong BuyUnlock the HK:9995 analyst price target with TipRanks PremiumSHJBF vs HK:9995Unlock the HK:9995 top-analyst price target with TipRanks Premium
HK:2696Shanghai Henlius Biotech, Inc. Class HHKD 47.76HKD 26.75B26.13-31.62%Strong BuyUnlock the HK:2696 analyst price target with TipRanks PremiumSHJBF vs HK:2696Unlock the HK:2696 top-analyst price target with TipRanks Premium

Performance Comparison

-60%-40%-20%0%20%40%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
SHJBFShanghai Junshi Biosciences Co., Ltd. Class H3.350.165.02%
HK:1801Innovent Biologics80.65-9.55-10.59%
HK:9688Zai Lab Ltd17.28-3.74-17.79%
HK:9926Akeso, Inc.78.90-39.40-33.31%
HK:9995RemeGen Co. Ltd. Class H65.90-26.95-29.03%
HK:2696Shanghai Henlius Biotech, Inc. Class H47.76-21.34-30.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts